statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2024. 'We entered this year with a clear focus: to deliver our 2024 financial targets while staying true to our...

Organon Reports Results for the First Quarter Ended March 31, 2024

Organon (NYSE: OGN), a global healthcare company with a focus on womens health, will release its first quarter 2024 financial results on May 2, 2024, prior to the companys webcast and conference call...

Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Prolia and Xgeva (denosumab) biosimilar HLX14 met the...

Phase 3 Comparative Clinical Study of Prolia and Xgeva (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints

Lauren Clason | (TNS) CQ-Roll Call
A recent tweak to a Medicaid formula could be behind the shake-up to inhaler products, a series of changes that have both benefited and harmed patients with asthma...

Experts say Medicaid rebate change is behind inhaler price cuts

Shareholders of Organon & Co (OGN) looking to boost their income beyond the stocks 6.1% annualized dividend yield can sell the October covered call at the 20 strike and collect the premium...

YieldBoost OGN From 6.1% To 21.1% Using Options

Essex Financial Services Inc. raised its position in Organon  Co. (NYSE:OGN  Free Report) by 8.1% in the third quarter, according to its most recent Form 13F filing with the Securities...

Essex Financial Services Inc. Raises Stake in Organon & Co. (NYSE:OGN)

Connor Clark  Lunn Investment Management Ltd. acquired a new position in Organon  Co. (NYSE:OGN  Free Report) during the 3rd quarter, according to the company in its most recent...

Connor Clark & Lunn Investment Management Ltd. Makes New Investment in Organon & Co. (NYSE:OGN)

The pharmaceutical company is developing biosimilars and women's health productsRelated Stocks: OGN, PFE, MRK, ABBV, SPY, IBB, TEVA, VTRS, AZN...

Organon's Valuation Is Not Expensive

Texas Permanent School Fund Corp decreased its stake in shares of Organon  Co. (NYSE:OGN  Free Report) by 2.0% in the 3rd quarter, according to the company in its most recent filing with...

Texas Permanent School Fund Corp Sells 1,088 Shares of Organon & Co. (NYSE:OGN)

Organon  Co. (NYSE:OGN  Free Report) had its price target hoisted by The Goldman Sachs Group from $16.00 to $18.00 in a research report sent to investors on Tuesday, Benzinga reports. The...

The Goldman Sachs Group Boosts Organon & Co. (NYSE:OGN) Price Target to $18.00

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Volume	1.52M
52-Wk High	$24.08
52-Wk Low	$10.84

Period	Estimated	Reported	Surprise	Result
Q1'24	$0.98	$1.22	24.76%	BEAT
Q4'23	$0.82	$0.88	7.36%	BEAT
Q3'23	$1.05	$0.87	-17.16%	MISSED
Q2'23	$0.97	$1.31	34.68%	BEAT
Q1'23	$1.17	$1.08	-7.35%	MISSED

OGN Organon & Co.

About

Feed

News

Sentiment

Earnings

Fundamentals